An alternative, though mutually not exclusive, reason for impaired effectiveness of the second TNFi in the PLR group is a higher proportion of patients with predictors of an impaired response to anti-TNF agents [7] in our study (normal CRP, HLA-B27 negativity, high BASFI levels, and frequent enthesitis). This evidence concerns the gene CRP and enthesitis.